Pitfalls and pearls with drug dosing in the critically ill obese patient: 10 statements to guide ICU practitioners

Jeffrey F. Barletta, Brian L. Erstad

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Obesity is highly prevalent in ICU patients presenting a number of challenges, one of which is drug dosing. There are limited high-quality data describing drug dosing in obesity, which can lead to dosing strategies that are suboptimal. For example, inappropriately using the wrong weight for weight-based dosing can lead to supratherapeutic drug concentrations and an adverse drug event or subtherapeutic drug concentrations and treatment failure. A generalized framework for decision making specific for obese patients is available that describes a step-by-step approach for constructing dosing regimens. This manuscript will build on that framework by providing pitfalls and pearls for clinicians to consider when making dosing decisions in critically ill patients with severe obesity.

Original languageEnglish (US)
Article number154105
JournalJournal of Critical Care
Volume71
DOIs
StatePublished - Oct 2022

Keywords

  • Adverse drug event
  • Critically ill
  • Drug dosing
  • Obesity
  • Pharmacokinetics

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Pitfalls and pearls with drug dosing in the critically ill obese patient: 10 statements to guide ICU practitioners'. Together they form a unique fingerprint.

Cite this